Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2026-03-16FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …
-
FDA label_change · 2024-06-11FDA Approved: HYDROCORTISONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a Supplemental Application for HYDROCORTISONE from Aurobindo Pharma Limited, typically indicating a label change for this gener…
-
FDA label_change · 2023-07-17FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling cha…
-
FDA label_change · 2017-01-13FDA Approved: CORDRAN — Supplemental Application (Almirall, LLC)
FDA approved a supplemental application for CORDRAN (flurandrenolide) filed by Almirall, LLC, likely affecting labeling.
-
FDA label_change · 2015-06-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2015-05-21FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.
-
FDA label_change · 2014-10-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, resulting in changes to the product labe…
-
FDA label_change · 2014-04-02FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA supplemental application for HALOG (halcinonide cream) submitted by Sun Pharmaceutical Industries, Inc., with the submission status indi…
-
FDA label_change · 2007-12-12FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…